Katzberg R W, Miller T L, Hayakawa K, Manzione J V, Tallents R H
Radiology. 1985 Apr;155(1):245-6. doi: 10.1148/radiology.155.1.3883421.
We compared patient morbidity associated with temporomandibular joint (TMJ) arthrography using both meglumine/sodium diatrizoate (60%) and the new monoacidic dimer, Hexabrix, in a double-blind randomized clinical trial in 31 patients. Patients experienced maximal discomfort from TMJ arthrography with the initial joint filling and joint distension; this rapidly resolved over 10 minutes. Delayed exacerbation of pain is less than described for shoulder arthrography. The newer contrast media promise to decrease patient morbidity with arthrography.
在一项针对31名患者的双盲随机临床试验中,我们比较了使用葡甲胺/泛影酸钠(60%)和新型单酸性二聚体Hexabrix进行颞下颌关节(TMJ)造影术时患者的发病率。患者在TMJ造影术的初始关节充盈和关节扩张时经历了最大程度的不适;这种不适在10分钟内迅速缓解。疼痛的延迟加剧比肩关节造影术的描述要少。新型造影剂有望降低造影术时患者的发病率。